University Of Texas/Texas Am Investment Management Co's Form 4 filing
Rein Therapeutics, Inc. (RNTX) · filed Jun 12, 2024
- Accession no.
- 0001019231-24-000025
- Filed
- Jun 12, 2024
- Trade date
- Jun 10-12, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market sales total $80.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| University Of Texas/Texas Am Investment Management CoCIK 0001019231 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2024 | Common Stock | SSaleDisposed | −9,577 | $3.30 | −$31,604.1 | 1,768,250 | Direct | |
| Jun 11, 2024 | Common Stock | SSaleDisposed | −5,250 | $3.25 | −$17,062.5 | 1,763,000 | Direct | |
| Jun 11, 2024 | Common Stock | SSaleDisposed | −502 | $3.35 | −$1,681.7 | 1,762,498 | Direct | |
| Jun 12, 2024 | Common Stock | SSaleDisposed | −9,341 | $3.25 | −$30,358.25 | 1,753,157 | Direct | |
| Jun 12, 2024 | Common Stock | SSaleDisposed | −1 | $3.28 | −$3.28 | 1,753,156 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.